ORPEA |
Market Closed -
Other stock markets
|
After market 01:44:59 pm | |||
| 13.6 EUR | +6.25% |
|
13.61 | +0.09% |
| Apr. 23 | ORPEA : Partial integration of the FY23 results |  |
| Apr. 19 | ORPEA : Ready for a refoundation full of thorns | |
| Sales 2023 | 5.2B 5.57B | Sales 2024 * | 5.44B 5.83B | Capitalization | 2.04B 2.18B |
|---|---|---|---|---|---|
| Net income 2023 * | -457M -490M | Net income 2024 * | -202M -216M | EV / Sales 2023 | 0.42 x |
| Net Debt 2023 * | 7.54B 8.08B | Net Debt 2024 * | 6.6B 7.07B | EV / Sales 2024 * | 1.59 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-0.01
x | Employees | 76,000 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 95.16% |
More Fundamentals
* Assessed data
More news
Latest transcript on ORPEA
More press releases
More news
| 1 day | +6.25% | ||
| 1 week | +10.28% | ||
| Current month | +34.15% | ||
| 1 month | +32.71% | ||
| 3 months | -1.45% | ||
| 6 months | -98.67% | ||
| Current year | -19.53% |
1 week
11.70
13.93
1 month
10.0013.93
Current year
9.9718.10
1 year
9.972 800.00
3 years
9.97111 100.00
5 years
9.97129 000.00
10 years
9.97129 000.00
| Managers | Title | Age | Since |
|---|---|---|---|
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Laurent Lemaire
DFI | Director of Finance/CFO | - | 21-12-07 |
| Chief Tech/Sci/R&D Officer | - | 22-10-09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 65 | 22-07-27 | |
Laurent Guillot
CEO | Chief Executive Officer | 54 | 22-06-30 |
Mireille Faugère
BRD | Director/Board Member | 66 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.13% | 18 M€ | +3.79% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 13.6 | +6.25% | 566 182 |
| 24-04-26 | 12.8 | +7.29% | 439,518 |
| 24-04-25 | 11.93 | -4.15% | 232,052 |
| 24-04-24 | 12.45 | -1.61% | 205,756 |
| 24-04-23 | 12.65 | +2.58% | 458,869 |
Real-time Euronext Paris, April 29, 2024 at 11:38 am EDT
More quotes
ORPEA is the European leader in global dependency care. The group operates retirement homes, follow-up care clinics, and psychiatric clinics.
At the end of 2022, ORPEA had a network of 992 facilities (90,860 beds) located in France (358 facilities; 33,462 beds), Benelux/the United Kingdom/Ireland (193 facilities; 10,708 beds), Central Europe (237 facilities; 23,765 beds), Eastern Europe (124 facilities; 12,764 beds), the Iberian Peninsula and Latin America (79 facilities; 10,007 beds) and China (1 facility; 154 beds)
The group has a real estate portfolio of nearly 2.3 million m2 with a value of EUR 6,500 million.
Net sales are distributed geographically as follows: France/Benelux/the United Kingdom/Ireland (59.9%), Central Europe (25.6%), Eastern Europe (9.3%), Iberian Peninsula and Latin America (5.1%) and other (0.1%).
Calendar
2024-05-13
- Q1 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
4
Last Close Price
12.8
EUR
Average target price
10,975
EUR
Spread / Average Target
+85,642.19%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.53% | 2.18B | |
| -1.73% | 1.41B | |
| -26.82% | 1.37B | |
| +18.56% | 1.32B | |
| +16.54% | 706M | |
| -2.73% | 464M | |
| +230.85% | 432M | |
| -7.77% | 322M | |
| +4.44% | 124M | |
| +39.04% | 88.82M |
- Stock Market
- Equities
- ORP Stock
